Search research articles
Contact Us
Filters
Showing results (171-180 of 328) with videos related to
Page
of 33
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 31, 2017
Dose-escalation study evaluating pegylated interferon alpha-2a in patients with cutaneous T-cell lymphoma
M Schiller, A Tsianakas, W Sterry, et al.
The Journal of Investigative Dermatology
|
June 16, 2001
The interferon inhibiting cytokine IK is overexpressed in cutaneous T cell lymphoma derived tumor cells that fail to upregulate major histocompatibility complex class II upon interferon-gamma stimulation
J Willers, A Häffner, K Zepter, et al.
Archives of Dermatological Research
|
March 5, 2002
Fibroblasts enhance the invasive capacity of melanoma cells in vitro
E Wandel, A Raschke, G Hildebrandt, et al.
Praxis
|
January 17, 2002
[Manifestations of the "pretherapeutic phase" of malignant melanoma of the skin in Switzerland 1996-1998]
M Schnorf, U Helfenstein, A Blum, et al.
Progress in Experimental Tumor Research
|
January 1, 1992
Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas
R Dummer, J Röger, T Vogt, et al.
The Journal of Investigative Dermatology
|
March 12, 2002
Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression
J Willers, M Urosevic, E Laine, et al.
The British Journal of Dermatology
|
August 9, 2020
Transient response to nivolumab and relapse after infliximab in a patient with primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma
F Toussaint, M Erdmann, E Grosch, et al.
Leukemia
|
April 28, 2015
Versican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy
K Fujii, M B Karpova, K Asagoe, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
December 1, 1990
A modified cytotoxicity assay with high sensitivity
U Keilholz, R Dummer, H Welters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2019
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
O Michielin, A C J van Akkooi, P A Ascierto, et al.
Page
of 33
Search research articles
Search
Showing results (171-180 of 328) with videos related to
Sort By:
Page
of 33
Journal of the European Academy of Dermatology and Venereology : JEADV
|
May 31, 2017
Dose-escalation study evaluating pegylated interferon alpha-2a in patients with cutaneous T-cell lymphoma
M Schiller, A Tsianakas, W Sterry, et al.
The Journal of Investigative Dermatology
|
June 16, 2001
The interferon inhibiting cytokine IK is overexpressed in cutaneous T cell lymphoma derived tumor cells that fail to upregulate major histocompatibility complex class II upon interferon-gamma stimulation
J Willers, A Häffner, K Zepter, et al.
Archives of Dermatological Research
|
March 5, 2002
Fibroblasts enhance the invasive capacity of melanoma cells in vitro
E Wandel, A Raschke, G Hildebrandt, et al.
Praxis
|
January 17, 2002
[Manifestations of the "pretherapeutic phase" of malignant melanoma of the skin in Switzerland 1996-1998]
M Schnorf, U Helfenstein, A Blum, et al.
Progress in Experimental Tumor Research
|
January 1, 1992
Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas
R Dummer, J Röger, T Vogt, et al.
The Journal of Investigative Dermatology
|
March 12, 2002
Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression
J Willers, M Urosevic, E Laine, et al.
The British Journal of Dermatology
|
August 9, 2020
Transient response to nivolumab and relapse after infliximab in a patient with primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma
F Toussaint, M Erdmann, E Grosch, et al.
Leukemia
|
April 28, 2015
Versican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy
K Fujii, M B Karpova, K Asagoe, et al.
Scandinavian Journal of Clinical and Laboratory Investigation
|
December 1, 1990
A modified cytotoxicity assay with high sensitivity
U Keilholz, R Dummer, H Welters, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2019
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
O Michielin, A C J van Akkooi, P A Ascierto, et al.
Page
of 33